Intranasal vaccine shows promise against COVID variants in hamsters

Intranasal mRNA-LNP vaccines show promise in Syrian golden hamsters, effectively reducing SARS-CoV-2 viral loads and lung pathology. The study suggests potential efficacy against new variants, setting the stage for future research in human applications.

How SaaS platforms are breaking the mold for clinical trials

SaaS platform are changing what is possible in delivering clinical trials. Credit: Frau aus UA via Shutterstock. While the digitization of clinical trials has enabled

August 6, 2024

Former J&J sales rep indicted on charges of defrauding Boston hospital

Dive Brief: A former DePuy Synthes sales representative and team lead was arrested this week for allegedly defrauding a Boston area hospital and lying to

June 28, 2023

HPV vaccination rates increase with school entry requirements, study finds

A new study from researchers at Wake Forest University School of Medicine shows that school entry requirements are linked to an increase in human papillomavirus

April 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.